IR-825,CAS#:1558079-49-4
IR-825
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-H-6012 | 10mg | 550.00 | + Add to cart |
|
| R-H-6012 | 25mg | 850.00 | + Add to cart |
|
| R-H-6012 | 50mg | 1250.00 | + Add to cart |
|
|
|
||||
Product description
IR-825 from ruixibiotech is a near-infrared dye (NIR). IR-825, after encapsulated into nanoparticles may be useful for cancer photothermal and photodynamic therapy. IR-825 nanoparticles showed pH-dependent fluorescence emission and excellent near-infrared (NIR) irradiation of cancer cells targeted in vitro to provide cytotoxicity. IR-825 nanoparticles showed efficient tumor homing together with rapid renal excretion behaviors, as revealed by MR imaging and confirmed by biodistribution measurement. Notably, when irradiated with an 808 nm laser, tumors on mice with IR-825 nanoparticle injection are completely eliminated without recurrence within 60 days, demonstrating the high efficacy of photothermal therapy.
| Appearance | Solid powder |
|---|---|
| Purity | 95.4% |
| Solubility | Soluble in DMSO/DMF |
| Molecular Weight | 823.4 Dalton |
| CAS Number | 1558079-49-4 |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
| Ex/Em | 810nm-830nm |
| Literature website | https://www.sciencedirect.com/science/article/pii/S2452199X21003492 |
| Literature name | A tumor-penetrable drug nanococktail made from human histones for interventional nucleus-targeted chemophotothermal therapy of drug-resistant tumors |
| Author of literature | Jianquan Guo, Dongsheng Tan, Chenmei Lou , Shiying Guo, Xing Jin , Haijing Qu, Lijia Jing , Sijin Li |
Document
Related Product

Items-$0.00

Email:
Tel.:
COA of IR-825
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


